FDA Alert: Compounding Pharmacy in California Warned After Particulates Found in Injections

On August 14, 2024, FDA received a complaint from a patient who noticed a black particulate in a vial of semaglutide distributed by Fullerton Wellness. On September 23, 2024, FDA received information from California regulatory authorities as part of ongoing collaboration between FDA and the state noting deficiencies found at Fullerton Wellness during a state inspection. After the state inspection, Fullerton Wellness voluntarily ceased operations.

[...]

FDA Alert: Class 1 Recall of Unauthorized Covid-19 Tests

This is a reprint of an FDA Alert. SD Biosensor Recalls STANDARD Q COVID-19 Ag Home Tests That Are Not Authorized, Cleared, or Approved by the FDA and May Give False Results The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious…

[...]

Counterfeit Drug Alerts & Drug Warnings Partnership for Safe Medicines

Drug Alerts & Warnings * 15 August 2007. Health Canada. Health Canada Reminds Consumers About the Risks of Buying Drugs Online * 4 April 2007. U.S. Food and Drug Administration. FDA WARNING: Risks of buying Accutane (isotretinoin) over the Internet * July 12, 2006. Health Canada Alert. Counterfeit Product Linked to Death of Ontario Horse…

[...]